GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (OTCPK:KYKOF) » Definitions » EPS (Diluted)

KYKOF (Kyowa Kirin Co) EPS (Diluted) : $1.06 (TTM As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Kyowa Kirin Co EPS (Diluted)?

Kyowa Kirin Co's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was $0.28. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $1.06.

Kyowa Kirin Co's EPS (Basic) for the three months ended in Jun. 2024 was $0.28. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $1.06.

Kyowa Kirin Co's EPS without NRI for the three months ended in Jun. 2024 was $0.28. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was $1.06.

During the past 12 months, Kyowa Kirin Co's average EPS without NRIGrowth Rate was 142.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 19.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Kyowa Kirin Co's highest 3-Year average EPS without NRI Growth Rate was 671.50% per year. The lowest was -84.60% per year. And the median was 6.00% per year.


Kyowa Kirin Co EPS (Diluted) Historical Data

The historical data trend for Kyowa Kirin Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co EPS (Diluted) Chart

Kyowa Kirin Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.14 0.84 0.86 0.74 1.05

Kyowa Kirin Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.36 0.18 0.28 0.24

Competitive Comparison of Kyowa Kirin Co's EPS (Diluted)

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's PE Ratio falls into.



Kyowa Kirin Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Kyowa Kirin Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(563.878-0)/537.635
=1.05

Kyowa Kirin Co's Diluted EPS for the quarter that ended in Jun. 2024 is calculated as

Diluted EPS (Q: Jun. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(146.611-0)/531.399
=0.28

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyowa Kirin Co  (OTCPK:KYKOF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Kyowa Kirin Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co Business Description

Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co Headlines